Benefits at 5 years of routine invasive strategy in Non-ST-Elevation Acute Coronary Syndromes

Original title: Impact of an invasive strategy on five years outcomein men and women with Non-ST-Elevation Acute Coronary Syndromes. Reference: Joakim Alfredsson et al. Am Heart J. 2014;Epub ahead of print.

 

This meta-analysis included patients with non-ST-elevation acute coronary syndrome (NSTE ACS) from randomized studies FRISC II, ICTUS and RITA 3 and compared the routine invasive strategy (n=2721) with coronary catheterization and, when possible, angioplasty or surgery vs. a more selective strategy (n=2746) consisting of initial stabilization with medical therapy, leaving coronary catheterization for patients with recurrent ischemia symptoms despite medical treatment, hemodynamically unstable, or showing signs of ischemia on a stress test. 

Women represented one third of overall cohort (n=1751), were of older age, smoked less and had higher hypertension rates than men. On the other hand, men often had a history of MI and revascularization.

After a 5 year follow up, routine invasive strategy in men reduced primary end point of cardiovascular death or AMI (15.6% vs 19.8%; p=0.01), and individual components, cardiovascular death (6.6% vs 8,7%; p=0.07) and AMI (10.8% vs 14.6%; p=0.01). These same points saw no significant change in women.

In the light of a risk stratified analysis, men presenting medium or high risk non ST elevation AMI at baseline, saw benefit from the routine invasive strategy. On the contrary, women in all risk subgroups saw a similar prognosis, regardless of treatment strategy. 

Conclusion

This meta-analysis based in three large randomized studies on non ST elevation AMI confirmed the long term benefit of routine invasive strategy in men, while women saw no significant benefit.

Editorial Comment

Subgroup analysis, especially if not pre specified by protocol, must be interpreted with caution. Even in this large dataset, the number of events in women was low and the difference between men and women could be the result of weak statistical power in women.

Among randomized patients undergoing routine invasive strategy, women often lack significant lesions (28.2% vs 9.3%) and are less likely to have 3 vessel lesions (21.1% vs 30.6%). 

To conclude, women had less severe coronary disease and this may have reduced the benefit of a routine invasive strategy. Today, guidelines have no specific recommendation as regards gender for non ST elevation AMI syndromes. 

SOLACI.ORG

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...